Annis Gardner Whiting Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$981K Sell
8,133
-575
-7% -$66.4K 0.16% 113
2025
Q4
$919K Buy
8,708
+3,344
+62% +$314K 0.17% 107
2025
Q3
$453K Buy
5,364
+1,166
+28% +$96K 0.09% 173
2025
Q2
$335K Sell
4,198
-22
-0.5% -$1.75K 0.12% 157
2025
Q1
$382K Sell
4,220
-1,062
-20% -$99.2K 0.16% 124
2024
Q4
$529K Sell
5,282
-507
-9% -$52.3K 0.15% 123
2024
Q3
$661K Sell
5,789
-1,366
-19% -$162K 0.19% 102
2024
Q2
$891K Buy
7,155
+132
+2% +$17K 0.25% 73
2024
Q1
$931K Buy
7,023
+3,117
+80% +$384K 0.33% 55
2023
Q4
$428K Buy
3,906
+428
+12% +$44.4K 0.19% 99
2023
Q3
$361K Buy
+3,478
New +$375K 0.19% 95

Other funds holding MRK

Annis Gardner Whiting Capital Advisors's MRK Position: Q1 2026 in Review

Annis Gardner Whiting Capital Advisors reduced its Merck (MRK) stake by 6.6% in Q1 2026, selling an estimated $66.4K and leaving 8,133 shares worth $981K. The position accounts for 0.16% of the portfolio, ranked #113.

Annis Gardner Whiting Capital Advisors first reported a position in MRK in Q3 2023 and has held it in 11 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Annis Gardner Whiting Capital Advisors held 8,133 shares of Merck worth $981K as of Q1 2026.
  • Annis Gardner Whiting Capital Advisors sold 575 Merck shares in Q1 2026, an estimated $66.4K.
  • Merck made up 0.16% of Annis Gardner Whiting Capital Advisors's portfolio in Q1 2026, its #113 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in Merck in Q3 2023 and has held it in 11 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.